Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009;3(2):142-51.
doi: 10.2976/1.3067922. Epub 2009 Jan 21.

Why does GM1 induce a potent beneficial response to experimental Chagas disease?

Why does GM1 induce a potent beneficial response to experimental Chagas disease?

S Cossy Isasi et al. HFSP J. 2009.

Abstract

Being one of the world's neglected diseases, Chagas has neither a vaccine nor a satisfactory therapy. Inoculation of murine models with the ganglioside GM1 has shown a strikingly nonlinear effect, leading to a strong decrease in parasite load at low doses but reverting to a load increase at high doses. Cardiocyte destruction concomitant with the disease is also significantly reduced by a moderate application of GM1. A mathematical model for the interaction between the parasite and the immune system is shown to explain these effects and is used to predict an optimal dosage that maximizes parasite removal with minimal cardiocyte destruction.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Parasite populations as a function of time for the indicated GM1 doses.
For each value of the dose we present the experimental data (Cossy Isasi et al., 1999) and model fits. The lines joining the experimental points are for eye guidance only. Note that the [GM1]=0.6 mg dose kills all the mice. The model describes what would occur to a putative immortal mouse, for which the parasite number becomes extremely high before being brought under control.
Figure 2
Figure 2. Number of cells destroyed by parasite action as a function of time after inoculation, for the indicated GM1 doses.
Intermediate doses strongly reduce cell damage at all times, while the largest dose strongly reduces the initial damage but has almost no effect at long times.
Figure 3
Figure 3. Asymptotic value of the predicted total cell loss as a function of GM1 dose (dots).
The dashed line corresponds to the maximum cell loss consistent with host survival. The range between the vertical solid lines is then the putative therapeutic dose range.

Similar articles

References

    1. Andersson, J, Örn, A, and Sunnemark, D (2003). “Chronic murine Chagas’ disease: the impact of host and parasite genotypes.” Immunol. Lett. IMLED610.1016/S0165-2478(03)00019-1 86, 207–212. - DOI - PubMed
    1. Andrade, A LSS, et al. (1996). “Randomized trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection.” Lancet LANCAO 348, 1407–1413. - PubMed
    1. Aufderheide, A C, et al. (2004). “A 9,000-year record of Chagas’ disease.” Proc. Natl. Acad. Sci. U.S.A. PNASA610.1073/pnas.0307312101 101, 2034–2039. - DOI - PMC - PubMed
    1. Brener, Z (1980). “Immunity to Trypanosoma cruzi.” Adv. Parasitol. ZZZZZZ 18, 247–292. - PubMed
    1. Bronia, D H, Aguerri, A M, and Bertetto, S T (1986). “Trypanosoma cruzi: changes in lipid composition during aging in culture.” Exp. Parasitol. ZZZZZZ 61, 151–159. - PubMed

LinkOut - more resources